Anti-platelet
Showing 1 - 25 of >10,000
Coronary Artery Disease Trial in Seoul (Clopidogrel monotherapy, Tailored anti-platelet therapy)
Not yet recruiting
- Coronary Artery Disease
- Clopidogrel monotherapy
- Tailored anti-platelet therapy
-
Seoul, Korea, Republic ofSeverance Hospital
Jul 3, 2023
Anti-coagulation and Anti-Platelet Therapies for Intracranial
Not yet recruiting
- Stroke
- Intracranial Atherosclerotic Stenosis (ICAS)
- MRI
- (no location specified)
Jun 7, 2023
Ischemic Stroke Trial in Daejeon (Aspirin, Clopidogrel)
Completed
- Ischemic Stroke
- Aspirin, Clopidogrel
-
Daejeon, Korea, Republic ofChungnam National University Hospital
Oct 10, 2022
Head Neck Cancer Trial in Charleston (Pembrolizumab, Clopidogrel, acetylsalicylic acid)
Recruiting
- Head and Neck Cancer
- Pembrolizumab
- +2 more
-
Charleston, South CarolinaMedical University of South Carolina
Dec 22, 2022
COPD, Emphysema, Emphysema or COPD Trial (dual anti-platelet therapy, Placebo)
Not yet recruiting
- COPD
- +2 more
- dual anti-platelet therapy
- Placebo
- (no location specified)
Oct 9, 2022
Dutch Adult Cardiac Surgery Population, and Effect on
Not yet recruiting
- P2Y12 Receptor Inhibitor
- +2 more
- TRACK-TCT
-
Enschede, Overijssel, NetherlandsThoraxcentrum Twente
Oct 12, 2022
Cardiovascular Diseases, Acute Coronary Syndrome Trial in Newark, Baltimore, Danville (clopidogrel, prasugrel)
Terminated
- Cardiovascular Diseases
- Acute Coronary Syndrome
-
Newark, Delaware
- +4 more
Mar 7, 2022
Anti-platelet Precision Medicine to Prevent Stroke Early
Completed
- Stroke
-
Seoul, Korea, Republic ofDong-Wha Kang
Feb 16, 2022
Patent Foramen Ovale, Migraine Trial (Aspirin 100mg, Metoprolol 25 Mg Oral Tablet, Clopidogrel 75mg)
Recruiting
- Patent Foramen Ovale
- Migraine
- Aspirin 100mg
- +3 more
-
Beijing, Beijing, ChinaFuwai Hospital
Jan 9, 2023
Platelet Aggregation Inhibitors, Coronary Heart Disease Trial in Lancaster (Clopidogrel, Aspirin)
Completed
- Platelet Aggregation Inhibitors
- Coronary Heart Disease
-
Lancaster, PennsylvaniaAmish Research Clinic
Feb 22, 2022
Percutaneous Intervention Trial in Shatin (Orsiro Mission, Resolute Onyx)
Recruiting
- Percutaneous Intervention
- Orsiro Mission
- Resolute Onyx
-
Shatin, Hong KongThe Chinese University of Hong Kong
Sep 19, 2022
Anti-platelet Drug Exposure on Platelet mRNA Splicing in Healthy
Withdrawn
- Thrombosis; Artery
- Ticagrelor Oral Tablet [Brilinta]
-
Washington, District of Columbia
- +1 more
Oct 21, 2021
Ischemic Stroke, Vertebral Artery Stenosis Trial in Beijing (Drug-eluting stenting plus aspirin and clopidogrel or ticagrelor,
Not yet recruiting
- Ischemic Stroke
- Vertebral Artery Stenosis
- Drug-eluting stenting plus aspirin and clopidogrel or ticagrelor
- +2 more
-
Beijing, ChinaXuanwu Hospital, Capital Medical University.
Jun 1, 2023
Platelet Activation Testing Before/After Anti-platelet Therapy, Healthy Trial in Boston (Aspirin, Clopidogrel)
Recruiting
- Platelet Activation Testing Before/After Anti-platelet Therapy
- Healthy
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Mar 31, 2022
Reduced Anti-coagulation/Anti-platelet Therapy in HeartMate II
Completed
- Anticoagulation
- Left Ventricular Assist Device
-
San Diego, California
- +17 more
Jun 23, 2022
Chronic Kidney Diseases Trial in Seoul (dual anti-platelet therapy at least 6 months, dual anti-platelet therapy 3months or
Recruiting
- Chronic Kidney Diseases
- dual anti-platelet therapy at least 6 months
- dual anti-platelet therapy 3months or less
-
Seoul, Korea, Republic ofDivision of Cardiology, Yonsei Cardiovascular Hospital, Yonsei U
Jul 28, 2021
Coronary Artery Disease Trial in Jacksonville (Ticagrelor 60mg, Clopidogrel)
Recruiting
- Coronary Artery Disease
- Ticagrelor 60mg
- Clopidogrel
-
Jacksonville, FloridaUniversity of Florida
Jul 6, 2022
Heart Diseases, Coronary Disease, Coronary Artery Disease Trial in Lancaster (Clopidogrel, Aspirin)
Enrolling by invitation
- Heart Diseases
- +9 more
-
Lancaster, PennsylvaniaAmish Research Clinic
Jan 24, 2022
Coronary Artery Disease, Atherosclerosis, Stent Placement Trial in Scottsdale, Boston, New York (Dual Antiplatelet (DAPT)
Active, not recruiting
- Coronary Artery Disease
- +2 more
- Dual Antiplatelet (DAPT) Therapy
- The Synergy® stent
-
Scottsdale, Arizona
- +2 more
Feb 15, 2022
Acute Coronary Syndrome (ACS), STEMI - ST Elevation Myocardial Infarction (MI), NSTEMI - Non-ST Segment Elevation MI Trial in
Active, not recruiting
- Acute Coronary Syndrome (ACS)
- +3 more
- CYP2C19 genotyping
-
Los Angeles, CaliforniaLAC+USC Medical Center
Sep 27, 2021
Clotting Factor VIII and Bleeding Adverse Reactions in Patients
Withdrawn
- Bleeding
- Ischemic Stroke
-
Guangzhou, Guangdong, ChinaZhujiang Hospital of Southern Medical University
Mar 22, 2022
Surgical Complication, Pain, Postoperative, Edema Face Trial in Edirne (Platelet rich fibrin application)
Completed
- Surgical Complication
- +2 more
- Platelet rich fibrin application
-
Edirne, Merkez, TurkeyTrakya University
Apr 13, 2022
Atrial Fibrillation Trial in Seoul (NOAC monotherapy, Dual therapy with apixaban and clopidogrel)
Recruiting
- Atrial Fibrillation
- NOAC monotherapy
- Dual therapy with apixaban and clopidogrel
-
Seoul, Korea, Republic ofSeverance Cardiovascular Hospital, Yonsei University Health Syst
Sep 10, 2021